Top pharmaceutical and biotech companies face a major slow down in sales growth over 2008â"14 according to a new report by independent business analyst Datamonitor. The report title "Pharmaceutical ....
SAFC Supply Solutions has announced the Asia Pacific availability of a product offer that is designed to meet the demands of the molecular diagnostics market and to provide single-point access to a range ....
Quintiles has announced the availability of anatomic pathology services through its central laboratory in Beijing. This is to help biopharmaceutical companies to develop more effective cancer treatments. ....
On March 31, Bayer Technology & Engineering (Shanghai) [BTES] and Werum Software & Systems will host the PAS-X Manufacturing Execution System (MES) Day for the pharmaceutical industry in China. This one-day ....
PPD has announced that its global central lab operations in Singapore has earned accreditation by the College of American Pathologists (CAP). This validates its ability to deliver high-quality, reliable ....
From March 30-31, Economist Conferences will host the inaugural Healthcare in Asia event in Singapore. The roundtable is part of a multi-year initiative and the theme of the first year's forum is "The ....
Bayer Schering Pharma has held two investigators meetings in Beijing, China and Seoul, Korea to announce the start of ADVISE, the Asia Pacific trial â" nifeDipine in combination with Valsartan to achIeve ....
TÜV SÜD PSB is now officially listed as one of World Health Organisation (WHO) Prequalified Quality Control Laboratories of Pharmaceuticals. This qualification recognises that the organization's ....
The industry report, "Acute Ischemic Stroke â" Drug Pipeline Analysis and Market Forecasts to 2015" by GlobalData identifies the key trends that are shaping and driving the global Acute Ischemic ....
Sinovac Biotech, a provider of biopharmaceutical products in China, has filed an application with China's State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against ....